Commercialization: Page 65
-
PharmaVoice Team/PharmaVoice
OUTLET
This year’s report on the pharmaceutical sector by Ernst & Young reminded me of that classic tale of technological transition — the fate of the wagon wheel maker. With the introduction of the automobile, one wheel maker was asked what business he was in. “I make wagon wheels," he replied. But...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Social Media
Patient Communities Improve Adherence TrendWatch: Two recent studies show that online patient communities not only provide support for patients that lead to better health outcomes, but they are also great resources for tracking and collecting health data and can be used for public health resear...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Virtual Pharma Rep Seeks to Reinvent Sales Model The Accelrys Modeling and Simulation Suite E-UPGRADES AND ENHANCEMENTS Trend: New dynamics within the pharmaceutical industry are prompting a paradigm shift to vir...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Trend: Healthcare agencies are shifting their service models to better address the market’s evolving approach to health and well-being. Featured Briefs: GSW Expands Health and Wellness Capabilities Newport Module Provides Biologics Intell...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Specialists More Likely to Open and Click Through Email Sidebar: Email Campaigns to Physicians by Type, July-December 2010 Branded Pharma Sites Help Drive Prospect, Patient Conversions Personalized Medicine Strategy Coul...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… GSK Medical Officer Honored Merck Scientists Recognized by PhRMA Kendle Recieves Achievement Award INDUSTRY at Large Going BIOSimiliar Parents Need Education about Nutrition Quote of the Month… Terry Hisey / Deloitte Podcasts Clinical Supply Optimization: Challenges & Solutions Thou...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Ready or Not Here Comes Pharma 3.0 Pharma 2.o was so last decade. Thanks to the good folks at Ernst & Young, who have coined the term Pharma 3.0 to describe a new ecosystem of healthcare, we are indeed entering new territory. As noted back in February, nontraditional pharma companies, such as...
By Taren Grom • May 24, 2011 -
PharmaVoice Team/PharmaVoice
From Blockbuster to Specialty Sales
Specialty pharma companies that solely focus on drugs targeted to a specific group of patients are seizing the opportunity to make inroads into physician prescribing practices by carefully tailoring their sales and marketing activities. From Blockbuster to Specialty Sales It seems as if all a...
By Denise Myshko • April 25, 2011 -
PharmaVoice Team/PharmaVoice
HBA's 2011: Rising Stars
These high-potential women, who represent all facets and disciplines of the life-sciences industry, are being recognized by their companies for: Significantly contributing to their organizations. Exemplifying true leadership and acting as a role model for others. Assisting those in subordinat...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Navigating the New Communications Landscape
The ways patients seek and share information—both in and out of the doctor’s office—are undergoing radical change. From the rise of the Internet to the explosion of social media to the growing patient demand for active participation in treatment decisions, a multitude of forces are converging to ...
By Chris DeAngelis • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Managing Change in Healthcare Market Research
After years of conservative stagnation healthcare market research is on the threshold of major and unstoppable change. How will this change impact research firms and their clients and how can it best be managed? Change Drivers There are two main drivers of change in the industry: 1. Technology wh...
By Peter Simpson • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Integrating Empowerment
The healthcare market continues to undergo a dramatic change that has created a storm of intersecting and interacting dynamics, points of view, and stakeholders. In the face of this increasing complexity, what is needed is the identification of foundational dynamics that clarify and unite this mu...
By Joseph Gattuso • April 25, 2011 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Honing the Edge
“Almost 70% of companies participating in a recent study use a decentralized market research structure, and yet often don’t provide training for the skills that make cross-functional decentralized structures work." Market research, long a key component of success in most pharma operations and s...
By Carolyn Gretton • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Tapping Into the Power by Getting Personal
More and more patients are using Facebook, YouTube, Twitter, and other social media outlets to discuss their health and treatments with peers and caregivers. Social media tools have become an effective way to expand reach, foster engagement, and increase access to credible, science-based health m...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
mHealth: Pharma's Next Blockbuster
The practice of mobile health, or mHealth as it is now known, has been around for decades. The first initiatives were designed to provide greater healthcare access to remote populations, mostly in developing countries. This trend continues and grows daily, providing many patients with a higher qu...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Anirvan GHOSH Roche Selects Head of CNS Discovery Global healthcare company Roche has named Anirvan Ghosh, Ph.D., head of discovery for central nervous system (CNS). Dr. Ghosh is based at Roche’s pharma research and early development organization in Basel, Switzerland, an...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Social Media
Social Media Trends, Regs, and Apps Featured Briefs: Nontraditional Players Get Into the Healthcare Game IBM’s Watson: “Alex, I’ll Take Medicine for $500 Please" Facebook Made Easier for Brands Apps… Amazon Enters Medical App Market Have a Great Idea for an App? Tweets… First Patient-to-Physicia...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: New System Uses Cloud to Streamline Content Management R&D Architecture Seeks to Speed Scientific Innovation In other technology news… E-UPGRADES AND ENHANCEMENTS Veeva Vault, a cloud-based, regulated content ...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: New Company Stakes Out Contract Diagnostics Category TGaS Advisors Expands Offerings in Managed Markets, Marketing In other news… ON THE SHELVES Trend: Recent growth in biomarker research is creating a need for clinical te...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: R&D Productivity Measures Consistently Undervalued Generics Firms Turning to M&A for Market Foothold Sidebar: Top 10 New Product Approvals in 2010 Specialty, Hospital Sales Forces Anticipate Double-Digit Growth P...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Showcase Feature — IRBs Watching the Protectors
Ever-changing clinical-trial regulations and continued growth in multicenter and international studies have resulted in an exponential increase in the volume of data generated for IRB review, including large numbers of individual adverse event (AE) reports, which often lack the context and detail...
By Carolyn Gretton • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Skill, Science, and the Art of the Conversation
Shifting marketplace dynamics have created unprecedented challenges for pharma industry sales organizations. Increasing hurdles to physician access, governmental and industry constraints on promotion, competition from generics, and diminishing degrees of differentiation among products have combin...
By Jennifer Munsie • March 28, 2011 -
PharmaVoice Team/PharmaVoice
Focus on Specialty Reps: From Information Source to Information Connector
TGaS Advisors Training & Development Practice There is a jump in demand for data on specialty sales areas, including oncology, biopharma, and niche therapy markets. As primary care recedes in relative importance in many — though not all — companies, large-tier companies are focusing more on h...
By Chris Goins • March 28, 2011 -
PharmaVoice Team/PharmaVoice
From KOL to COL: Regional Influencers are Critical to Commercial Model Re-invention
The commercial model in pharmaceutical sales is under dramatic pressure that necessitates a radical shift in how drug companies interact with key customers. Primarily, marketers must explore more effective conduits for accessing physicians who have organized into ever more complex networks and no...
By Kelly Myers • March 28, 2011 -
PharmaVoice Team/PharmaVoice
KOL Mapping: The GPS of Thought Leader Identification
Mapping charts the quickest route to finding the right KOLs. With all of today’s technology-driven data capture capabilities, there is a lot of thought leader information to be garnered, but all that knowledge is only as good as its relevance. KOL mapping serves as a guiding tool that cuts throug...
By PharmaVoice Team • March 28, 2011
Previous
